Abstract:The high expression of PACAP (pituitary adenylate cyclase-activating polypeptide)-preferring receptor PAC1 is associated with nerve injury and tumors. Our previous report (Yu R, et al. PLoS One 2012; 7: e51811) confirmed the dimerization of PAC1 and found that the M-PAC1 mutation in the N-terminal first Cys/Ala lost the ability to form dimers. In this study, Chinese hamster ovary (CHO-K1) cells overexpressing wild-type PAC1 (PAC1-CHO) had significantly higher anti-apoptotic activities against serum withdrawal-induced apoptosis associated with a lower caspase 3 activity and a higher Bcl-2 level in a ligand-independent manner than those of CHO cells overexpressing the mutant M-PAC1 (M-PAC1-CHO). PAC1-CHO had significantly higher β-catenin, cyclin D1 and c-myc levels corresponding to the Wnt/β-catenin signal than did M-PAC1-CHO. In addition, the Wnt/β-catenin pathway inhibitor XAV939 significantly inhibited the anti-apoptotic activities of PAC1-CHO. Top-flash assays demonstrated that PAC1-CHO had a significantly stronger Wnt/β-catenin signal than did M-PAC1-CHO. Acetylcysteine (NAC) as an inhibitor of the dimerization of PAC1 inhibited the anti-apoptotic activities that were endowed by PAC1 and decreased the Wnt/β-catenin signal in Top-flash assays. In the PAC1 Tet (tetracycline)-on inducible gene expression system by doxycycline (Dox), higher expression levels of PAC1 resulted in higher anti-apoptotic activities that were associated with a stronger Wnt/β-catenin signal. A similar correlation was also found with the down-regulation of PAC1 in the Neuro2a neuroblastoma cell. BiFC combined with fluorescence confocal imaging indicated that during serum-withdrawal-induced apoptosis, PAC1 dimers displayed significant endocytosis. These findings indicate that PAC1 has ligand-independent and dimer-dependent intrinsic/basal activity, conferring cells with anti-apoptotic activities against serum withdrawal, which is involved in the Wnt/β-catenin signal and is associated with the endocytosis of PAC1 dimers. The discovery and study of the dimer-dependent basal activity of PAC1 not only help us understand the physiological and pathological role of PAC1 but also promote the development of drugs targeting PAC1.

Pac1 is A Direct Transcription Target of E2f-1 in Apoptotic Signaling

E2F1 Renders Prostate Cancer Cell Resistant to ICAM-1 Mediated Antitumor Immunity by NF-κB Modulation.

PAC1 Phosphatase is a Transcription Target of P53 in Signalling Apoptosis and Growth Suppression

A Molecular Link Between E2F-1 and the MAPK Cascade.

The Phosphatase PAC1 Acts As a T Cell Suppressor and Attenuates Host Antitumor Immunity

E2F1 Transactivates IQGAP3 and Promotes Proliferation of Hepatocellular Carcinoma Cells Through IQGAP3-mediated PKC-alpha Activation.

Dimer-Dependent Intrinsic/Basal Activity of the Class B G Protein-Coupled Receptor PAC1 Promotes Cellular Anti-Apoptotic Activity Through Wnt/β-Catenin Pathways That Are Associated with Dimer Endocytosis

Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor.

E2f1 Induces Tumor Cell Survival Via Nuclear Factor-Kappa B-Dependent Induction of Egr1 Transcription in Prostate Cancer Cells

Identification Of E1af As A Target Gene Of E2f1-Induced Apoptosis In Response To Dna Damage

The E2f Family and the Role of E2f1 in Apoptosis

E2F1-mediated Ectopic Expression of PP1A Promotes Breast Cancer Progression Via Activation of YAP1.

Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1.

Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition

Supplementary Figure 1 from Dual Specificity Phosphatase 1/CL100 is a Direct Transcriptional Target of E2F-1 in the Apoptotic Response to Oxidative Stress

PP2A Regulates the Pro-apoptotic Activity of FOXO1

The Transcription Factor E2F1 Promotes Dopamine‐evoked Neuronal Apoptosis by a Mechanism Independent of Transcriptional Activation

PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis

Hypoxia‐inducible Factor‐1α and Nuclear Factor‐κb Play Important Roles in Regulating Programmed Cell Death Ligand 1 Expression by Epidermal Growth Factor Receptor Mutants in Non‐small‐cell Lung Cancer Cells

Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Tumor Necrosis Factor-Α-induced Apoptosis in Endothelial Colony-Forming Cells

Data from The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function